Clinical and Ultrasonic Evaluation of Spleen Size during Peripheral Blood Progenitor Cell Mobilization by Filgrastim: Results of an Open-Label Trial in Normal Donors

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 7, 2009, Pages 827-834

  Stiff, Patrick J ^a   Bensinger, William ^b   Abidi, Muneer H ^c   Gingrich, Roger ^d   Artz, Andrew S ^e   Nademanee, Auayporn ^f   Hansen, Keith S ^g   Sobczak, Christopher ^h   Cutler, Corey ⁱ   Bolwell, Brian ^j   Shore, Tsiporah B ^k   Lazarus, Hillard M ^l   Yeager, Andrew M ^m   Lovelace, Wade ⁿ   Guo, Matthew ⁿ   Dreiling, Lyndah ⁿ  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^f City of Hope ^*  (United States)

^g Northwest Marrow Transplant Program   (United States)

^h MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁱ DANA FARBER CANCER INSTITUTE   (United States)

^j TAUSSIG CANCER INSTITUTE   (United States)

^k NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^l UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^m UNIVERSITY OF ARIZONA   (United States)

ⁿ AMGEN INC   (United States)

more..

Author keywords

Stem cell, Mobilization, Spenomegaly, Spleen size

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABDOMINAL PAIN; ADULT; AGED; ARTHRALGIA; ARTICLE; BACKACHE; BONE PAIN; CLINICAL EXAMINATION; CLINICAL TRIAL; DONOR; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; ECHOGRAPHY; EVENING DOSAGE; FEMALE; HUMAN; LEUKAPHERESIS; MALE; MORNING DOSAGE; MUSCULOSKELETAL PAIN; NAUSEA; PAIN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SPLEEN RUPTURE; SPLEEN SIZE; TACHYCARDIA; THORAX PAIN; VOMITING;

ADOLESCENT; ADULT; AGED; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LIVING DONORS; MALE; MIDDLE AGED; ORGAN SIZE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SPLEEN; SPLENIC RUPTURE;

EID: 67149102667     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.03.015     Document Type: Article

References (28)

1. Gratwohl A., Baldomero H., Frauendorfer K., and Urbano-Ispizua A. EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant 37 (2006) 1069-1085
2. National Marrow Donor Program. http://www.marrow.org/PHSYCIAN/Adv_in_Auto_Allo_Tx/Hematopoietic_Cell_So urces/Tai/index.html 2007.
3. Crawford J., Ozer H., Stoller R., et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325 (1991) 164-170
4. Anderlini P., Rizzo J.D., Nugent M.L., Schmitz N., Champlin R.E., and Horowitz M.M. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant 27 (2001) 689-692
5. Becker P.S., Wagle M., Matous S., et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 3 (1997) 45-49
6. Falzetti F., Aversa F., Minelli O., and Tabilio A. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet 353 (1999) 555
7. Balaguer H., Galmes A., Ventayol G., Bargay J., and Besalduch J. Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor. Transfusion 44 (2004) 1260-1261
8. Dincer A.P., Gottschall J., and Margolis D.A. Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization. J Pediatr Hematol Oncol 26 (2004) 761-763
9. Nuamah N.M., Goker H., Kilic Y.A., Dagmoura H., and Cakmak A. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (G-CSF). A case report and review of the literature. Haematologica 91 (2006) ECR08
10. Zimmer B.M., Berdel W.E., Ludwig W.D., Notter M., Reufi B., and Thiel E. Fatal spleen rupture during induction chemotherapy with rh GM-CSF priming for acute monocytic leukemia. Clinical case report and in vitro studies. Leuk Res 17 (1993) 277-283
11. Kasper C., Jones L., Fujita Y., Morgenstern G.R., Scarffe J.H., and Chang J. Splenic rupture in a patient with acute myeloid leukemia undergoing peripheral blood stem cell transplantation. Ann Hematol 78 (1999) 91-92
12. O'Malley D.P., Whalen M., and Banks P.M. Spontaneous splenic rupture with fatal outcome following G-CSF administration for myelodysplastic syndrome. Am J Hematol 73 (2003) 294-295
13. Arshad M., Seiter K., Bilaniuk J., et al. Side effects related to cancer treatment: CASE 2. Splenic rupture following pegfilgrastim. J Clin Oncol 23 (2005) 8533-8534
14. Hatzimichael E., Benetatos L., Stebbing J., Kapsali E., Panayiotopoulou S., and Bourantas K.L. Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim support. Clin Lab Haematol 28 (2006) 416-418
15. Kuendgen A., Fenk R., Bruns I., et al. Splenic rupture following administration of pegfilgrastim in a patient with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 38 (2006) 69-70
16. Watring N.J., Wagner T.W., and Stark J.J. Spontaneous splenic rupture secondary to pegfilgrastim to prevent neutropenia in a patient with non-small-cell lung carcinoma. Am J Emerg Med 25 (2007) 247-248
17. Veerappan R., Morrison M., Williams S., and Variakojis D. Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation and review of the literature. Bone Marrow Transplant 40 (2007) 361-364
18. Pitini V., Ciccolo A., Arrigo C., Aloi G., Micali C., and LaTorre F. Spontaneous rupture of spleen during peripheral blood stem cell mobilization in a patient with breast cancer. Haematologica 85 (2000) 559-560
19. de la Rubia J., Martínez C., Solano C., et al. Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Bone Marrow Transplant 24 (1999) 723-728
20. Kröger N., Renges H., Sonnenberg S., et al. Stem cell mobilisation with 16 μg/kg vs 10 μg/kg of G-CSF for allogeneic transplantation in healthy donors. Bone Marrow Transplant 29 (2002) 727-730
21. Platzbecker U., Prange-Krex G., Bornhauser M., et al. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion 41 (2001) 184-189
22. Stroncek D., Shawker T., Follmann D., and Leitman S.F. G-CSF-induced spleen size changes in peripheral blood progenitor cell donors. Transfusion 43 (2003) 609-613
23. Picardi M., DeRosa G., and Selleri C. Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization. Haematologica 88 (2003) 794-800
24. De Odorico I., Spaulding K.A., Pretorius D.H., Lev-Toaff A.S., Bailey T.B., and Nelson T.R. Normal splenic volumes estimated using three-dimensional ultrasonography. J Ultrasound Med 18 (1999) 231-236
25. Morrison S.J., Wandycz A.M., Akashi K., Globerson A., and Weissman I.L. The aging of hematopoietic stem cells. Nat Med 2 (1996) 1011-1016
26. Wagers A.J., Allsopp R.C., and Weissman I.L. Changes in integrin expression are associated with altered homing properties of Lin-/loThy1.1loSca-1+c-kit+ hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor. Exp Hematol 30 (2002) 176-185
27. Tamayo S.G., Rickman L.S., Mathews W.C., et al. Examiner dependence on physical diagnostic tests for the detection of splenomegaly: a prospective study with multiple observers. J Gen Intern Med 8 (1993) 69-75
28. Anderlini P., Donato M., Chan K.W., et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion 39 (1999) 555-560